Chinese biopharmaceutical firm Adlai Nortye bags $100m in a Series D round

Retrieved on: 2021-07-13 09:45:00

Tags for this article:

Click the tags to see associated articles and topics

Chinese biopharmaceutical firm Adlai Nortye bags $100m in a Series D round. View article details on hiswai:

Excerpt

Hangzhou Adlai Nortye Biopharma Co., Ltd, a Chinese clinical-stage biopharmaceutical firm that makes immuno-oncology medicines, has raked in ...

Article found on: www.dealstreetasia.com